Physician profile
Mark Wilson
NPI 1225233604
$2,225.35
in general payments reported to CMS, 2019-2025
20 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $14.35 · 2021: $816 · 2022: $264 · 2023: $248 · 2024: $360 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,069.90 | 2021-2024 | Intellis Adaptivestim |
| Abbvie INC. | $297.28 | 2022-2025 | Botox |
| Mdd US Operations, LLC | $134.88 | 2019 | |
| Relievant Medsystems, INC. | $134.24 | 2021 | |
| Forte Bio-Pharma LLC | $94.31 | 2025 | Prolate, Nalocet, Tanlor |
| Sanofi-Aventis U.S. LLC | $91.61 | 2021-2023 | |
| Allergan, INC. | $49.95 | 2021-2022 | |
| Bioventus LLC | $45.73 | 2019-2023 | Durolane |
| Ibsa Pharma INC. | $45.15 | 2020-2021 | |
| Abbott Laboratories | $40.56 | 2021 | |
| Medtronic USA, INC. | $38.10 | 2019 | |
| Averitas Pharma INC. | $24.00 | 2023 | Qutenza |
| Scilex Pharmaceuticals INC. | $23.83 | 2023 | Ztlido |
| Daiichi Sankyo INC. | $22.72 | 2019 | |
| Collegium Pharmaceutical, INC. | $22.39 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $22.18 | 2019 | |
| Protega Pharmaceutials INC | $22.01 | 2025 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $20.48 | 2025 | |
| Zyla Life Sciences, INC. | $13.49 | 2019 | |
| Sentynl Therapeutics, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.